agilon health (NYSE:AGL) Shares Down 2.8% - Time to Sell?

agilon health, inc. (NYSE:AGL - Get Free Report) shares fell 2.8% during mid-day trading on Thursday . The company traded as low as $2.29 and last traded at $2.29. 1,094,778 shares were traded during mid-day trading, a decline of 78% from the average session volume of 4,934,709 shares. The stock had previously closed at $2.35.

Analyst Upgrades and Downgrades

AGL has been the topic of a number of recent research reports. Wells Fargo & Company cut their price target on agilon health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 13th. Royal Bank of Canada lifted their target price on shares of agilon health from $3.00 to $3.50 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a report on Friday, March 21st. Robert W. Baird dropped their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Finally, Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $3.25 to $5.00 in a report on Friday, April 25th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $4.79.

agilon health Price Performance

The business has a 50-day moving average of $3.79 and a 200 day moving average of $3.19. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $933.46 million, a P/E ratio of -2.40 and a beta of 0.38.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter last year, the firm posted ($0.02) earnings per share. The company's revenue for the quarter was down 4.5% compared to the same quarter last year. On average, sell-side analysts predict that agilon health, inc. will post -0.59 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of AGL. Ieq Capital LLC acquired a new position in shares of agilon health during the fourth quarter valued at about $26,000. Signaturefd LLC boosted its stake in agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the last quarter. Humankind Investments LLC bought a new stake in agilon health during the 4th quarter worth approximately $30,000. Raymond James Financial Inc. purchased a new stake in shares of agilon health in the fourth quarter worth approximately $33,000. Finally, Cerity Partners LLC bought a new position in shares of agilon health in the fourth quarter valued at approximately $34,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.